NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today

Novavax (NASDAQ:NVAX) stock is falling hard on Wednesday as investors react to the vaccine company’s earnings report for the fourth quarter of 2024.Let’s dig into everything that has investors in NVAX stock disappointed today below!NVAX Earnings Hit StockNovavax reported earnings per share of -$1.44 during the quarter.That’s worse than the -35 cents per share that Wall Street was expecting.However, it is better than the -$2.28 from the same time last year.Revenue of $291.34 million also failed to meet the a ...